# Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

> **NCT01964573** · PHASE1 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 48 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Rotigotine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01964573
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964573, "Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01964573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*